Vizamyl

Flutemetamol F-18 · FLUTEMETAMOL F-18 4.05 mCi/mL · Solution · Intravenous · GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)

NDC 17156-0067-30 · 1 VIAL, MULTI-DOSE in 1 CONTAINER / 30 mL in 1 VIAL, MULTI-DOSE · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed

$86,400.00

Reported to Texas DSHS · 2026 annual filing · Medi-Physics

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

BAMF Health, Inc.United States
positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 414, LLCUnited States
positron emission tomography drug production
Cardinal Health 414, LLCUnited States
manufacture · positron emission tomography drug production
Cardinal Health 418, Inc.United States
manufacture · positron emission tomography drug production
Cardinal Health, Inc.United States
manufacture · positron emission tomography drug production
Cardinal Health, Inc.United States
manufacture · positron emission tomography drug production
Cardinal Health, Inc.United States
manufacture · positron emission tomography drug production
Cardinal Health, Inc.United States
manufacture · positron emission tomography drug production
Essential Isotopes, LLCUnited States
positron emission tomography drug production
GE Healthcare ASNorway
analysis · manufacture
GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)United States
analysis
Pharmalogic Austin, LLCUnited States
positron emission tomography drug production
Pharmalogic Cincinatti, LLCUnited States
positron emission tomography drug production
Pharmalogic Colorado, LLCUnited States
positron emission tomography drug production
Pharmalogic Georgia, LLCUnited States
positron emission tomography drug production
Pharmalogic Los Angeles, LLCUnited States
positron emission tomography drug production
Pharmalogic New York City, LLCUnited States
positron emission tomography drug production
Precision Nuclear, LLCUnited States
positron emission tomography drug production
The University of Utah DBA Cyclotron Radiochemistry Lab Huntsman Cancer InstituteUnited States
positron emission tomography drug production

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA203137
TE code: —
Approval date: Oct 25, 2013
Patents / exclusivity: 2 patents, 0 exclusivities

Type	Number / code	Expires
patent	8916131	Sep 16, 2028
patent	8916131	Sep 16, 2028

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Flutemetamol F-18 (Solution)

Labeler	Strength	First seen	Last seen
GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)	FLUTEMETAMOL F-18 4.05 mCi/mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vizamyl — NDC 17156-0067-30," retrieved September 3, 2026, https://drugdashboards.com/drug/17156006730.

Free to cite with attribution — see how the data is put together.